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The roots of the science of photobiology and photo-
medicine are ancient. Belief in the health-giving proper-
ties of sunlight stems from sun worship reinforced by an 
awareness that all life on earth owes its existence to the 
sun. In the late 19th century this image of sunlight was 
given scientific rationale with recognition that microor-
ganisms were killed by ultraviolet radiation and was 
further enhanced when sunlight and artificial ultraviolet 
sources were used in the prevention and treatment of 
vitamin-D deficient rickets as well as the treatment of 
some forms of cutaneous tuberculosis. Because sun could 
kill germs, make strong bones, and treat disease, "rosy" 
cheeks and other cutaneous evidence of sun exposure 
carried the message of glowing health. But, by the middle 
of the 20th century, specific chemotherapy for tubercu-
losis and other infections replaced ultraviolet photother-
apy or heliotherapy, and vitamen D was added to food. 
The harmful effects of ultraviolet came to be widely 
recognized. Then except for partially successful photo-
therapy of certain skin diseases, photomedicine began to 
drift back into history and folk medicine. 
However, in the past 2 decades there has emerged a 
new science of photomedicine based on molecular pho-
tobiology, scientific method, and creative use of sophis-
ticated electrooptical capabilities. The optical properties 
of human skin are being defined and quantified and 
techniques are available to selectively modify these prop-
erties. Ultraviolet and visible radiation can now be used 
to prevent brain damage in newborn infants, successfully 
treat chronic common skin diseases, prevent certain 
forms of blindness, and perform bloodless surgery. 
The potentials in photo medicine are greatly enhanced 
by advances in several disciplines. Advances in electron-
ics, physics, and optics have expanded the capabilities in 
diagnostics, treatment delivery systems, and quantitative 
measurements of photobiologic endpoints. Many impor-
tant observations at the cellular and molecular level have 
been made by scientists working with plants, bacteria, 
and simple organisms and by investigators in the field of 
photosynthesis and photochemistry. Details of photobi-
ochemistry are being delineated; synthetic photoacti-
vated organic molecules are being designed as probes. 
The in vivo effects of ultraviolet radiation on normal and 
abnormal cells of skin, blood, and immune system are 
being studied and manipulated. Photochemical changes 
in circulating proteins, metabolites, and mediators are 
being described and the information applied to diagnose, 
explain, and treat a vru'iety of illnesses. The task of the 
cutaneous photobiologists is made much less overwhelm-
ing by this basic reseru'ch, and it is a major challenge to 
successfully channel this reseru'ch into a mode useful to 
dermatology. 
The 30th Annual Symposium on the Biology of Skin 
was sponsored by the University of Oregon Health Sci -
ences Center, the Oregon Regional Primate Reseru'ch 
Center and The Society for Investigative Dermatology. 
Support for the meeting came from a grant from the 
Public Health Service AM 09431, the Medical Research 
Foundation of Oregon, the Beaverton Research Foun-
dation and The Society for Investigative Dermatology. 
Major contributions were received from Bristol-Myers 
Products, Charles of the Ritz Group, Ltd., Cheseborough-
Pond's Inc., Estee Lauder, Inc., The Gilette Company, 
Hoffman-LaRoche, Inc.! Johnson & Johnson Baby Prod-
ucts Co., Lever Brothers Co., Menley & James Labora-
tories, Ortho Pharmaceutical Corp. (Dermatological Di-
vision), Orentreich Medical Group, The Procter and 
Gamble Co., Revlon Reseru'ch Center, Inc., Schering 
Corp., Smith Kline and French Laboratories, Stiefel Lab-
oratories, Inc., Syntex Laboratories, Inc., The Upjohn 
Co., \lick Divisions Research and Development, and 
Westwood Pharmaceuticals, Inc. 
Other contributions were received from Beecham 
Products, Cosmair Inc., Dermik Laboratories Inc. , Elder 
Pharmaceuticals, Herbert Laboratories, Hoechst-Rous-
sel Pharmaceuticals, Inc., National Biological Corp., 
Neutrogena Dermatologies and Owen Laboratories. 
Kirk D. Wuepper, M.D. 
Leonard C. Harber, M.D. 
Frederick D . Malkinson, M.D., D.M.D. 
John A. Parrish, M.D. 
